Patent battles could choke coronavirus drugs pipeline: Carlos Correa

Correa is executive director, South Centre, an inter-governmental organisation which works on various issues affecting developing countries such as climate change, food security, etc

Coronavirus, vaccine, covid
Premium

Representative image

Anoo Bhuyan | IndiaSpend
New Delhi: India and South Africa are currently leading a call at the World Trade Organization (WTO) for intellectual property (IP) exemptions on items like diagnostic kits, vaccines, medicines, personal protective equipment and ventilators required to fight Covid-19. These exemptions from the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement would mean that WTO member countries would not necessarily need to grant or enforce intellectual property rights related to Covid-19 drugs, vaccines, diagnostics and other technologies.
According to the submission by the governments of India and South Africa, the waiver ought to continue until “the majority of the world's population has developed immunity” and until “widespread vaccination is in place globally”.
In the

Also Read

Covid-19 found in all districts, tally around 400: Uttarakhand Health Secy

India 5th worst-hit Covid-19 country with 246,662 cases: Johns Hopkins data

Covid-19 lockdown a success, no community transmission in India: ICMR

Delhi coronavirus update: Capital reports 2,737 Covid-19 cases, 19 deaths

India may face ICU beds shortage during Covid-19 peak in mid-Nov: Report

Pfizer, BioNTech seek emergency use of coronavirus shots in US

Coronavirus LIVE: India records 46,288 new cases; tally rises to 9,050,613

Assam coronavirus update: State's Covid-19 death toll rises to 971

Hong Kong bans AI flights for 5th time as passengers test Covid-19 positive

Govt releases backend code of Aarogya Setu to enhance transparency

First Published: Nov 21 2020 | 9:38 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com